Skip to main content Accessibility help

The Emergence of Decreased Susceptibility to Vancomycin in Staphylococcus epidermidis

  • Denise O. Garrett (a1), Elise Jochimsen (a1), Kate Murfitt (a2), Bertha Hill (a1), Sigrid McAllister (a1), Pat Nelson (a2), Richard V. Spera (a2), Richard K. Sall (a2), Fred C. Tenover (a1), Judy Johnston (a3), Barbara Zimmer (a3) and William R. Jarvis (a1)...



Coagulase-negative staphylococci (CNS) are the major cause of nosocomial bloodstream infection. Emergence of vancomycin resistance among CNS is a serious public health concern, because CNS usually are multidrug-resistant, and glycopeptide antibiotics, among which only vancomycin is available in the United States, are the only remaining effective therapy. In this report, we describe the first bloodstream infection in the United States associated with a Staphylococcus epidermidis strain with decreased susceptibility to vancomycin.


We reviewed the hospital's microbiology records for all CNS strains, reviewed the patient's medical and laboratory records, and obtained all available CNS isolates with decreased susceptibility to vancomycin. Blood cultures were processed and CNS isolates identified by using standard methods; antimicrobial susceptibility was determined by using minimum inhibitory concentration (MIC) and disk-diffusion methods. Nares cultures were obtained from exposed healthcare workers (HCWs) to identify possible colonization by CNS with decreased susceptibility to vancomycin.


The bloodstream infection by an S epidermidis strain with decreased susceptibility to vancomycin occurred in a 49-year-old woman with carcinoma. She had two blood cultures positive for CNS; both isolates were S epidermidis. Although susceptible to vancomycin by the disk-diffusion method (16-17 mm), the isolates were intermediate by MIC (8-6 μg/mL). The patient had received an extended course of vancomycin therapy; she died of her underlying disease. No HCW was colonized by CNS with decreased susceptibility to vancomycin.


This is the first report in the United States of bloodstream infection due to S epidermidis with decreased susceptibility to vancomycin. Contact precautions likely played a role in preventing nosocomial transmission of this strain, and disk-diffusion methods may be inadequate to detect CNS with decreased susceptibility to vancomycin.


Corresponding author

Hospital Infections Program, Centers for Disease Control and Prevention, Mail Stop E69, 1600 Clifton Rd, Atlanta, GA 30333


Hide All
1. Shulman, JA, Nahmias, AJ. Staphylococcal infection: clinical aspects. In: Cohen, JO, ed. The Staphylococci. New York, NY: Wiley-Interscience; 1972:457502.
2. Banerjee, SN, Emori, TG, Culver, DH, Gaynes, RP, Jarvis, WR, Horan, T, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991;91(3B):86S89S.
3. Schaberg, DR, Culver, DH, Gaynes, RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;91 (3B):72S75S.
4. Emory, TG, Gaynes, RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6: 428442.
5. Martin, MA, Pfaller, MA, Wenzel, RP. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 1989;110:916.
6. Karchmer, AW, Archer, GL, Dismukes, WE. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guide to therapy. Ann Intern Med 1983;98:447455.
7. Archer, GL, Tenenbaum, MJ. Antibiotic resistant Staphylococcus epidermidis in patients undergoing cardiac surgery. Antimicrob Agents Chemother 1980;17:269272.
8. Griffith, RS. Vancomycin use-an historical review. J Antimicrob Chemother 1988;32:2426.
9. Watanakunakorn, C. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin. J Antimicrob Chemother 1988;22:321324.
10. Hancock, R, Fitz-James, PC. Some differences in the action of penicillin, bacitracin, and vancomycin on Bacillus megaterium . J Bacteriol 1964;87:10441050.
11. Jordan, DC, Inniss, WE. Selective inhibition of ribonucleic acid synthesis in Staphylococcus aureus by vancomycin. Nature 1959;184:18941895.
12. Goldstein, FW, Coutrot, A, Sieffer, A, Acar, JF. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother 1990;34:899900.
13. Veach, LA, Pfaller, MA, Barrett, M, Koontz, FP, Wenzel, RP. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol 1990;28:20642068.
14. Schwalbe, RS, Stapleton, JT, Gilligan, PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987;316:927931.
15. Schwalbe, RS, Ritz, WJ, Verma, PR, Barranco, EA, Gilligan, PH. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus . J Infect Dis 1990;161:4551.
16. Tuazon, CU, Miller, H. Clinical and microbiologic aspects of serious infections caused by Staphylococcus epidermidis . Scand J Infect Dis 1983;15:347360.
17. Cherubin, CE, Corrado, ML, Sierra, MF, Gombert, ME, Shulman, M. Susceptibility of gram-positive cocci to various antibiotics including cefotaxime, moxalactam, and N-formimidoyl thienamycin. Antimicrob Agents Chemother 1981;20:553555.
18. Sanyal, D, Johnson, AP, George, RC, Cookson, BD, Williams, AJ. Peritonitis due to vancomycin-resistant Staphylococcus epidermidis . Lancet 1991;337:54.
19. Krcmery, V, Trupl, J, Drgona, L, Lacka, J, Kukuckova, E, Oravcova, E. Nosocomial bacteremia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin. Eur J Clin Microbiol Infect Dis 1996;15:259261.
20. Kloos, WE, Bannerman, TL. Staphylococcus and Micrococcus. In: Manual of Clinical Microbiology, 6th ed. Washington, DC: American Society for Microbiology; 1995:282298.
21. National Committee for Clinical Laboratory Standards. Second Performance Standards for Antimicrobic Disk Susceptibility Tests. Approved standard MZ-A25. Villanova, PA NCCLS; 1982.
22. Washington JA, II, Sutter, VL. Dilution susceptibility test: agar and macro-broth dilution procedures. In: Lennette, EA, Ballows, A, Hausler, WJ Jr, Truant, JP, eds. Manual of Clinical Microbiology. 3rd ed. Washington, DC: American Society for Microbiology; 1980:453458.
23. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 4th ed. Approved standard M7-A4. Wayne, PA NCCLS; 1997.
24. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. 6th ed. Approved standard M2-A6. Wayne, PA: NCCLS; 1997.
25. Clark, NC, Cooksey, RC, Hill, BC, Swenson, JM, Tenover, FC. Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother 1993;37:23112317.
26. Satake, S, Clark, N, Rimland, D, Nolte, FS, Tenover, FC. Detection of vancomycin-resistant enterococci in fecal samples by using the polymerase chain reaction. J Clin Microbiol 1997;35:23252330.
27. Bannerman, TL, Hancock, GA, Tenover, FC, Miller, JM. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus . J Clin Microbiol 1995;33:551555.
28. Sattler, FR, Foderano, JB, Aber, RC. Staphylococcus epidermidis bacteremia associated with vascular catheters: an important cause of febrile morbidity in hospitalized patients. Infect Control 1984;5:279283.
29. Smith, DJ, Kaplan, RL, Landau, W, Trenholme, GM. Speciation and antibiotic susceptibility patterns of coagulase-negative staphylococci. Eur J Clin Microbiol 1982;1:228232.
30. Swenson, JM, Hill, BC, Thornsberry, C. Problems with the disk diffusion test for detection of vancomycin resistance in enterococci. J Clin Microbiol 1989;27:21402142.
31. Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR 1997;46:756766.
32. Centers for Disease Control and Prevention. Update: Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR 1997;46:813815.
33. Smith, TL, Pearson, M, Tenover, F, Jarvis, WR. Emergence of vancomycin resistance in Staphylococcus aureus: epidemiology and clinical significance. N Engl J Med. In press.


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed